These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
810 related articles for article (PubMed ID: 1677108)
1. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Graham NM; Zeger SL; Park LP; Phair JP; Detels R; Vermund SH; Ho M; Saah AJ Lancet; 1991 Aug; 338(8762):265-9. PubMed ID: 1677108 [TBL] [Abstract][Full Text] [Related]
2. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group. Chaisson RE; Keruly J; Richman DD; Moore RD Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373 [TBL] [Abstract][Full Text] [Related]
3. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR Recomm Rep; 1992 Apr; 41(RR-4):1-11. PubMed ID: 1348843 [TBL] [Abstract][Full Text] [Related]
4. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144 [TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. Carr A; Tindall B; Penny R; Cooper DA AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714 [TBL] [Abstract][Full Text] [Related]
6. Aerosolized pentamidine as primary prophylaxis for Pneumocystis carinii pneumonia: efficacy, mortality and morbidity. Lidman C; Berglund O; Tynell E; Lindbäck S; Elvin K AIDS; 1994 Jul; 8(7):935-9. PubMed ID: 7946102 [TBL] [Abstract][Full Text] [Related]
7. The effects on survival of early treatment of human immunodeficiency virus infection. Graham NM; Zeger SL; Park LP; Vermund SH; Detels R; Rinaldo CR; Phair JP N Engl J Med; 1992 Apr; 326(16):1037-42. PubMed ID: 1347907 [TBL] [Abstract][Full Text] [Related]
8. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145 [TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536 [TBL] [Abstract][Full Text] [Related]
10. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121 [TBL] [Abstract][Full Text] [Related]
12. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. Kovacs JA; Masur H Clin Infect Dis; 1992 May; 14(5):1005-9. PubMed ID: 1350925 [TBL] [Abstract][Full Text] [Related]
13. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA Ann Intern Med; 1992 Jul; 117(2):106-11. PubMed ID: 1351371 [TBL] [Abstract][Full Text] [Related]
14. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. Leoung GS; Feigal DW; Montgomery AB; Corkery K; Wardlaw L; Adams M; Busch D; Gordon S; Jacobson MA; Volberding PA N Engl J Med; 1990 Sep; 323(12):769-75. PubMed ID: 1975426 [TBL] [Abstract][Full Text] [Related]
15. Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine-treated AIDS patients. Girard PM; Landman R; Gaudebout C; Lepretre A; Lottin P; Michon C; De Truchis P; Matheron S; Camus F; Farinotti R Lancet; 1989 Jun; 1(8651):1348-53. PubMed ID: 2567372 [TBL] [Abstract][Full Text] [Related]
16. Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort. Longini IM; Clark WS; Karon JM Am J Epidemiol; 1993 Jun; 137(11):1229-40. PubMed ID: 8100682 [TBL] [Abstract][Full Text] [Related]
17. Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities. Holmberg SD; Conley LJ; Buchbinder SP; Judson FN; Bush TJ; Katz MH; Penley KA; Hershow RC AIDS; 1993 May; 7(5):699-704. PubMed ID: 8318177 [TBL] [Abstract][Full Text] [Related]
18. [The prevention of Pneumocystis carinii pneumonia by pentamidine inhalation]. Jablonowski H; Elsing C; Erckenbrecht J; Hengels KH; Strohmeyer G Dtsch Med Wochenschr; 1992 Jul; 117(31-32):1181-4. PubMed ID: 1353721 [TBL] [Abstract][Full Text] [Related]
19. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. Centers for Disease Control (CDC) MMWR Suppl; 1989 Jun; 38(5):1-9. PubMed ID: 2524643 [TBL] [Abstract][Full Text] [Related]
20. Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity. Slavin MA; Hoy JF; Stewart K; Pettinger MB; Lucas CR; Kent SJ AIDS; 1992 Oct; 6(10):1169-74. PubMed ID: 1466849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]